SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 26, 2001
STRATEGIC DIAGNOSTICS INC.
--------------------------------------------------
(Exact name of Registrant as specified in charter)
Delaware 0-68440 56-1581761
(State or Other Jurisdiction (Commission (I.R.S. Employer
of Incorporation or file Identification
Organization) number) Number)
111 Pencader Drive
Newark, Delaware 19702
(Address of principal executive offices)
(302) 456-6789
(Registrant's telephone number, including area code)
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits.
99 Press Release dated July 26, 2001.
Item 9. Regulation FD Disclosure
As is more fully described in the attached press release that is
incorporated herein by reference Strategic Diagnostics Inc. ("SDI") announced
preliminary results for the second quarter of 2001 as well as the certification
of SDI's Mycotoxin test kits by the USDA and the retention of Goldman Sachs &
Co. as the company's financial advisor.
This report, including the news release incorporated herein, contains
forward-looking statements reflecting SDI's current expectations. When used in
this press release, the words "anticipate", "enable", "estimate", "intend",
"expect", "believe", "potential", "will", "should", "project" and similar
expressions as they relate to SDI are intended to identify said forward-looking
statements. Investors are cautioned that all forward-looking statements involve
risks and uncertainties, which may cause actual results to differ from those
anticipated by SDI at this time. Such risks and uncertainties include, without
limitation, changes in demand for products, delays in product development,
delays in market acceptance of new products, ability of manufacturers of non-GMO
food products to charge premiums to consumers, successful integration of the
AZUR Environmental business if and when the acquisition is completed, retention
of customers and employees, adequate supply of raw materials, inability to
obtain required government approvals, modifications of government regulations,
modifications to development and sales relationships, construction delays or
cost overruns in the Maine expansion project, delays or unanticipated costs
relating to the consolidation of the California facility, the ability to meet
increased market demand, the ability to achieve anticipated growth, increasing
dependence on the sale of certain products, competition, protection of
intellectual property, non-infringement of intellectual property, seasonality,
and other factors more fully described in SDI's public filings with the U.S.
Securities and Exchange Commission.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
STRATEGIC DIAGNOSTICS INC.
Date: July 26, 2001 By: /s/ Arthur A. Koch, Jr.
--------------------------------
Name: Arthur A. Koch, Jr.
Title: Chief Operating Officer
EXHIBIT INDEX
Exhibit
No. Description
- ------- -----------
99 Press Release dated July 26, 2001.